Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Enoxacin
Therapeutic Area : Neurology
Study Phase : Phase I/ Phase II
Sponsor : Weizmann Institute of Science | Apotex Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Enoxacin for Amyotrophic Lateral Sclerosis (ALS)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 12, 2021
Lead Product(s) : Enoxacin
Therapeutic Area : Neurology
Highest Development Status : Phase I/ Phase II
Sponsor : Weizmann Institute of Science | Apotex Inc
Deal Size : Inapplicable
Deal Type : Inapplicable